According to a new report, published by KBV research, The Global Sterility Testing Market size is expected to reach $2 billion by 2029, rising at a market growth of 10.2% CAGR during the forecast period.
The Kits & Reagents market is leading the segment in the Global Sterility Testing Market by Product in 2022; thereby, achieving a market value of $1.1 billion by 2029. This growth is attributed to the availability of several products that reduce the possibility of false negative or false positive outcomes. Another one is sterility testing pumps, which can be easily integrated into any testing environment and aid in maximizing safety & streamlining productivity. Over the anticipated period, the segment's growth will be aided by the rising demand for similar products.
The Direct Inoculation market would register a CAGR of 10.9% during (2023 - 2029). To enable the identification of both aerobic & anaerobic bacteria, direct inoculation involves directly injecting the test object into two different types of media. Both media are incubated for 14 days after injection. To look for signs of microbial contamination, periodic observations, and a final observation are made throughout the testing period.
The Pharmaceuticals & Biologicals market generated the high revenue in the Global Sterility Testing Market by Application in 2022; thereby, achieving a market value of $1.1 billion by 2029. Parenteral, aerosol, eye drops, ointments, and other products fall under the pharmaceutical group. These dose formulations are the most often employed. One of the main drivers of the market's expansion is the rising demand for dosage forms on a global scale. Further bolstering the need for sterility testing of pharmaceuticals is the growing frequency of recalls of these dosage forms due to a lack of sterility.
The Biotechnology Companies market would experience a CAGR of 10.4% during (2023 - 2029). The majority of biotech businesses began concentrating on their research & development for the detection of leads that could identify and cure the SARS-CoV-2 infection. One of the most important tools they used was sterility testing. Further, the increased government funding is supporting market growth in this segment.
The North America market dominated the Global Sterility Testing Market by Region in 2022; thereby, achieving a market value of $829.9 million by 2029. The Europe market is anticipated to grow at a CAGR of 9.8% during (2023 - 2029). Additionally, The Asia Pacific would witness a CAGR of 10.8% during (2023 - 2029).
Full Report: https://www.kbvresearch.com/sterility-testing-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country-wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Thermo Fisher Scientific, Inc., Charles River Laboratories International, Inc., SGS S.A., Merck KGaA, BioMérieux S.A., WuXi AppTec Co., Ltd., Sartorius AG, Samsung Biologics Co., Ltd. (Samsung Group), Nelson Laboratories, LLC (Sotera Health Company) and Pacific Biolabs, Inc.
By Product
By Test Type
By Application
By End User
By Geography
Companies Profiled
Unique Offerings 
